Cardiovascular medicine | GPnotebook TV

Cardiovascular medicine videos

Real-world data in guiding treatment decisions – Dr Ander Cohen and Dr Harry Gibbs in conversation (Content from Bristol Myers Squibb Australia Pty Ltd and Pfizer Australia Pty Ltd.)

1 February 2023

PP-ELI-AUS-1095

Coenzyme Q10 supplements for statin-related muscle symptoms

30 August 2022

Dr Anish Kotecha examines a recent update from the Specialist Pharmacy Service on the role of coenzyme Q10 supplementation for managing or preventing muscle-related symptoms associated with statin use.

Miconazole oral gel to treat oral thrush in adults taking a statin

1 August 2022

Dr Anish Kotecha summarises an update from the Specialist Pharmacy Service on the potential drug interactions between oral miconazole and certain statins.

Statins update: the nocebo effect and statin use in older adults

12 July 2022

Pro

Dr Kevin Fernando provides an update on statins, focusing on studies exploring a potential "nocebo" effect (whereby negative expectations result in adverse effects).

Dapagliflozin for chronic heart failure with reduced ejection fraction: NICE TA679

2 November 2021

Dr Anish Kotecha outlines the recent technology appraisal regarding the use of dapagliflozin as an add-on to optimised standard care for chronic heart failure with reduced ejection fraction.

Superficial venous thrombosis

27 October 2021

Pro

Dr Kevin Fernando investigates the detection and management of superficial venous thrombosis in primary care.

Diagnosis and management of abdominal aortic aneurysm: NICE guideline NG156

14 December 2020

Dr Kevin Fernando summarises this guideline published in March 2020, focusing on the aspects most relevant to primary care.

Post-congress review: ESC Congress 2020

6 October 2020

Drs Amar Puttanna, Kevin Fernando, Patrick Holmes and Amrit Lamba discuss the key highlights from the recent European Society of Cardiology's virtual congress.

Venous thromboembolic diseases: NICE guideline NG158

23 September 2020

Dr David Millar-Jones examines the key points for primary care from this recently updated guideline.

Direct-acting oral anticoagulants (DOACs): bleeding risk and reversal agents

10 September 2020

Dr Julie Oliver discusses this topic in the context of a recent update from the Medicines and Healthcare products Regulatory Agency (MHRA).

Cardiovascular medicine videos

Real-world data in guiding treatment decisions – Dr Ander Cohen and Dr Harry Gibbs in conversation (Content from Bristol Myers Squibb Australia Pty Ltd and Pfizer Australia Pty Ltd.)

PP-ELI-AUS-1095

Coenzyme Q10 supplements for statin-related muscle symptoms

Miconazole oral gel to treat oral thrush in adults taking a statin

Statins update: the nocebo effect and statin use in older adults

Dapagliflozin for chronic heart failure with reduced ejection fraction: NICE TA679

Superficial venous thrombosis

Diagnosis and management of abdominal aortic aneurysm: NICE guideline NG156

Post-congress review: ESC Congress 2020

Venous thromboembolic diseases: NICE guideline NG158

Direct-acting oral anticoagulants (DOACs): bleeding risk and reversal agents

This account does not have a GPnotebook Pro registration

Congratulations!

Sign in to watch videos

Already have a GPnotebook account?

Not yet registered with GPnotebook?

Stay up to date...

Before you go...